ClearArc Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,673
| Closed | -$961K | – | 357 |
|
|
2019
Q3 | $961K | Buy |
9,673
+72
| +0.7% | +$6.84K | 0.28% | 85 |
|
|
2019
Q2 | $888K | Sell |
9,601
-1,221
| -11% | -$116K | 0.26% | 93 |
|
|
2019
Q1 | $1.02M | Sell |
10,822
-268
| -2% | -$23.4K | 0.27% | 87 |
|
|
2018
Q4 | $711K | Sell |
11,090
-5,188
| -32% | -$383K | 0.21% | 113 |
|
|
2018
Q3 | $1.46M | Buy |
16,278
+84
| +0.5% | +$7.42K | 0.19% | 122 |
|
|
2018
Q2 | $1.29M | Sell |
16,194
-921
| -5% | -$76.5K | 0.18% | 128 |
|
|
2018
Q1 | $1.53M | Sell |
17,115
-798
| -4% | -$76.6K | 0.23% | 105 |
|
|
2017
Q4 | $1.87M | Buy |
17,913
+181
| +1% | +$20.4K | 0.25% | 91 |
|
|
2017
Q3 | $2.59M | Buy |
17,732
+35
| +0.2% | +$4.77K | 0.39% | 63 |
|
|
2017
Q2 | $2.3M | Buy |
17,697
+97
| +0.6% | +$11.9K | 0.37% | 64 |
|
|
2017
Q1 | $2.19M | Buy |
17,600
+186
| +1% | +$22.3K | 0.36% | 67 |
|
|
2016
Q4 | $2.02M | Sell |
17,414
-191
| -1% | -$21.3K | 0.36% | 72 |
|
|
2016
Q3 | $1.84M | Sell |
17,605
-1,204
| -6% | -$130K | 0.35% | 69 |
|
|
2016
Q2 | $1.85M | Sell |
18,809
-268
| -1% | -$27.7K | 0.36% | 70 |
|
|
2016
Q1 | $1.91M | Sell |
19,077
-134
| -0.7% | -$13.8K | 0.4% | 60 |
|
|
2015
Q4 | $2.3M | Sell |
19,211
-193
| -1% | -$22.3K | 0.48% | 50 |
|
|
2015
Q3 | $2.1M | Sell |
19,404
-226
| -1% | -$28K | 0.44% | 56 |
|
|
2015
Q2 | $2.27M | Sell |
19,630
-3,610
| -16% | -$413K | 0.42% | 57 |
|
|
2015
Q1 | $2.68M | Buy |
23,240
+5,318
| +30% | +$635K | 0.55% | 46 |
|
|
2014
Q4 | $2M | Buy |
17,922
+1,113
| +7% | +$117K | 0.41% | 66 |
|
|
2014
Q3 | $1.59M | Buy |
16,809
+707
| +4% | +$63.8K | 0.36% | 81 |
|
|
2014
Q2 | $1.38M | Sell |
16,102
-494
| -3% | -$37.6K | 0.32% | 93 |
|
|
2014
Q1 | $1.16M | Buy |
16,596
+390
| +2% | +$30.9K | 0.29% | 100 |
|
|
2013
Q4 | $1.37M | Sell |
16,206
-822
| -5% | -$65K | 0.35% | 86 |
|
|
2013
Q3 | $1.31M | Buy |
17,028
+1,008
| +6% | +$70.6K | 0.37% | 76 |
|
|
2013
Q2 | $937K | Buy |
+16,020
| New | +$964K | 0.25% | 119 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
ClearArc Capital's CELG Position: Q4 2019 in Review
ClearArc Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,673 shares — an estimated $961K sold.
ClearArc Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.68M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- ClearArc Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- ClearArc Capital sold 9,673 Celgene Corp shares in Q4 2019, an estimated $961K.
- ClearArc Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- ClearArc Capital's Celgene Corp position peaked at $2.68M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.